Combination Trial of Intravenous Paracetamol - Morphine for Treating Acute Renal Colic in Emergency Setting: An Optimum Treatment
NCT ID: NCT03865004
Last Updated: 2019-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
136 participants
INTERVENTIONAL
2015-10-17
2018-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravenous Paracetamol or Morphine for the Treatment of Acute Flank Pain
NCT01318187
Comparison of the Analgesic Efficacy of Dexketoprofen Trometamol, Meperidine, and Paracetamol in Renal Colic
NCT06558916
IV Paracetamol, Dexketoprofen or Morphine for the Treatment of Low Back Pain
NCT01422291
Intravenous Acetaminophen and Morphine Versus Intravenous Morphine Alone for Acute Pain in the Emergency Department
NCT04148495
Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management
NCT02187614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Paracetamol+Morphine
1gr paracetamol plus 0.1 mg/kg morphine were performed simultanously
Dexketoprofen plus Morphine
Intravenous 75 mg Dexketoprofen plus 0,1 mg/kg morphine were performed simultanously
Placebo plus Morphine
100 cc NaCl plus 0.1 mg/kg morphine were performed simultanously
Paracetamol
Paracetamol+Morphine
1gr paracetamol plus 0.1 mg/kg morphine were performed simultanously
Dexketoprofen plus Morphine
Intravenous 75 mg Dexketoprofen plus 0,1 mg/kg morphine were performed simultanously
Placebo plus Morphine
100 cc NaCl plus 0.1 mg/kg morphine were performed simultanously
Dexketoprofene
Paracetamol+Morphine
1gr paracetamol plus 0.1 mg/kg morphine were performed simultanously
Dexketoprofen plus Morphine
Intravenous 75 mg Dexketoprofen plus 0,1 mg/kg morphine were performed simultanously
Placebo plus Morphine
100 cc NaCl plus 0.1 mg/kg morphine were performed simultanously
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paracetamol+Morphine
1gr paracetamol plus 0.1 mg/kg morphine were performed simultanously
Dexketoprofen plus Morphine
Intravenous 75 mg Dexketoprofen plus 0,1 mg/kg morphine were performed simultanously
Placebo plus Morphine
100 cc NaCl plus 0.1 mg/kg morphine were performed simultanously
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Akdeniz University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
firatbektas
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.